ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018
Amsterdam, The Netherlands – 09 November 2018
read more
Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada.
Amsterdam, The Netherlands – 07 November 2018
read more
Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-inflammatory drugs with a fourth indication : Bronchopulmonary Dysplasia.
Amsterdam, The Netherlands – 06 November 2018
read more
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investment today
Amsterdam, The Netherlands – 15 October 2018
read more
Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled
Amsterdam, The Netherlands – 03 October 2018
read more
CryoSave has fully equipped this new safe and secure sample storage BioBank in its state-of-the-art central laboratory in Geneva, Switzerland especially designed for optimal cryopreservation of all biological samples and therefore provide peace of mind to institutional clients and families.
Amsterdam, The Netherlands – 13 September 2018
read more
Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.
Amsterdam, The Netherlands – 31 August 2018
read more
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investment today
Amsterdam, The Netherlands – 29 August 2018
read more
Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017.
Amsterdam, The Netherlands – 15 August 2018
read more
Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017.
Amsterdam, The Netherlands – 18 July 2018
read more
